Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis.

Campbell LA, Yaraei K, Van Lenten B, Chait A, Blessing E, Kuo CC, Nosaka T, Ricks J, Rosenfeld ME.

Microbes Infect. 2010 Aug;12(8-9):598-606. doi: 10.1016/j.micinf.2010.04.001. Epub 2010 Apr 22.

2.

IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.

Chen S, Shimada K, Zhang W, Huang G, Crother TR, Arditi M.

J Immunol. 2010 Nov 1;185(9):5619-27. doi: 10.4049/jimmunol.1001879. Epub 2010 Oct 8.

3.

CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.

Zafiratos MT, Manam S, Henderson KK, Ramsey KH, Murthy AK.

Pathog Dis. 2015 Oct;73(7). pii: ftv052. doi: 10.1093/femspd/ftv052. Epub 2015 Jul 27.

4.

Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.

Nazzal D, Therville N, Yacoub-Youssef H, Garcia V, Thomsen M, Levade T, Segui B, Benoist H.

J Infect Dis. 2010 Sep 1;202(5):782-90. doi: 10.1086/655700.

PMID:
20632890
5.

Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.

Wang C, Gao D, Kaltenboeck B.

J Infect Dis. 2009 Jul 15;200(2):279-87. doi: 10.1086/599796.

PMID:
19508161
6.

SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.

Yang T, Stark P, Janik K, Wigzell H, Rottenberg ME.

J Immunol. 2008 Mar 15;180(6):4040-9.

7.

Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults.

Ferrari M, Poli A, Olivieri M, Verlato G, Tardivo S, Nicolis M, Campello C.

Infection. 2002 Aug;30(4):203-7.

PMID:
12236561
8.

Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.

Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ.

J Infect Dis. 2001 Jan 15;183(2):232-238. Epub 2000 Dec 13.

PMID:
11120929
9.

Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice.

Tiirola T, Erkkilä L, Laitinen K, Leinonen M, Saikku P, Bloigu A, Jauhiainen M.

Scand J Clin Lab Invest. 2002;62(6):477-84.

PMID:
12469903
10.

Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction.

Rodriguez N, Fend F, Jennen L, Schiemann M, Wantia N, Prazeres da Costa CU, Dürr S, Heinzmann U, Wagner H, Miethke T.

J Immunol. 2005 Apr 15;174(8):4836-44.

11.

Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.

Ezzahiri R, Stassen FR, Kurvers HR, Dolmans V, Kitslaar PJ, Bruggeman CA.

APMIS. 2006 Feb;114(2):117-26.

PMID:
16519748
12.

Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae.

Rodriguez N, Wantia N, Fend F, Dürr S, Wagner H, Miethke T.

Eur J Immunol. 2006 May;36(5):1145-55.

13.

A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.

Sorrentino R, Yilmaz A, Schubert K, Crother TR, Pinto A, Shimada K, Arditi M, Chen S.

Cell Immunol. 2015 Mar;294(1):25-32. doi: 10.1016/j.cellimm.2015.01.007. Epub 2015 Jan 30.

14.

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.

Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK.

Circulation. 2001 Jun 12;103(23):2834-8.

PMID:
11401941
15.

Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Damy SB, Higuchi ML, Timenetsky J, Reis MM, Palomino SP, Ikegami RN, Santos FP, Osaka JT, Figueiredo LP.

BMC Microbiol. 2009 Sep 10;9:194. doi: 10.1186/1471-2180-9-194.

16.

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

Aalto-Setälä K, Laitinen K, Erkkilä L, Leinonen M, Jauhiainen M, Ehnholm C, Tamminen M, Puolakkainen M, Penttilä I, Saikku P.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):578-84.

PMID:
11304476
17.

Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.

Erkkilä L, Saario E, Laitinen K, Saikku P, Leinonen M.

Vaccine. 2008 May 12;26(20):2503-9. doi: 10.1016/j.vaccine.2008.03.034. Epub 2008 Apr 3.

PMID:
18433949
18.

Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.

Bandholtz L, Kreuger MR, Svanholm C, Wigzell H, Rottenberg ME.

Clin Exp Immunol. 2002 Dec;130(3):393-403.

19.

Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.

Bobryshev YV, Orekhov AN, Killingsworth MC, Lu J.

J Innate Immun. 2011;3(5):483-94. doi: 10.1159/000327522. Epub 2011 May 31.

20.

Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?

Papaetis GS, Anastasakou E, Orphanidou D.

Eur J Intern Med. 2009 Oct;20(6):579-85. doi: 10.1016/j.ejim.2009.05.006. Epub 2009 Jun 7. Review.

PMID:
19782917

Supplemental Content

Support Center